PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
46.67%
Revenue growth above 1.5x M7U.DE's 8.10%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
48.07%
Positive gross profit growth while M7U.DE is negative. John Neff would see a clear operational edge over the competitor.
1383.88%
EBIT growth above 1.5x M7U.DE's 26.86%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
1383.88%
Operating income growth above 1.5x M7U.DE's 56.27%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
202.37%
Net income growth above 1.5x M7U.DE's 58.83%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
211.76%
EPS growth above 1.5x M7U.DE's 62.50%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
211.76%
Diluted EPS growth above 1.5x M7U.DE's 62.50%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-8.33%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-8.33%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-100.00%
Dividend reduction while M7U.DE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
64.44%
10Y revenue/share CAGR at 75-90% of M7U.DE's 76.48%. Bill Ackman would press for new markets or product lines to narrow the gap.
64.44%
5Y revenue/share CAGR under 50% of M7U.DE's 155.87%. Michael Burry would suspect a significant competitive gap or product weakness.
64.44%
3Y revenue/share CAGR above 1.5x M7U.DE's 22.58%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
133.07%
Net income/share CAGR at 50-75% of M7U.DE's 186.76%. Martin Whitman might question if the firm’s product or cost base lags behind.
133.07%
5Y net income/share CAGR above 1.5x M7U.DE's 86.12%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
133.07%
Below 50% of M7U.DE's 737.50%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
17.85%
Equity/share CAGR of 17.85% while M7U.DE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
17.85%
5Y equity/share CAGR above 1.5x M7U.DE's 1.38%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
17.85%
Below 50% of M7U.DE's 198.10%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.18%
Our AR growth while M7U.DE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
5.26%
Inventory shrinking or stable vs. M7U.DE's 16.35%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
3.63%
Asset growth above 1.5x M7U.DE's 2.30%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
18.30%
BV/share growth above 1.5x M7U.DE's 9.15%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.61%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
22.56%
We expand SG&A while M7U.DE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.